Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

[Inhibitory effects of cyclooxygenase-2 selective inhibitor Celecoxib on human nephroblastoma].

Hu XL, Zhao LS, Liu W, Shu JB, Xu L, Wang ZF.

Zhonghua Bing Li Xue Za Zhi. 2012 May;41(5):340-1. doi: 10.3760/cma.j.issn.0529-5807.2012.05.012. Chinese. No abstract available.

PMID:
22883675
2.

Celecoxib derivative OSU-03012 inhibits the proliferation and activation of hepatic stellate cells by inducing cell senescence.

Zhang J, Wang M, Zhang Z, Luo Z, Liu F, Liu J.

Mol Med Rep. 2015 Apr;11(4):3021-6. doi: 10.3892/mmr.2014.3048. Epub 2014 Dec 4.

PMID:
25482718
3.

[Effect of a selective COX-2 inhibitor on cell proliferation and apoptosis in human gastric cancer cell line BGC-823].

Li Q, Peng J, Zhang GY.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 Dec;33(12):1123-8. Chinese.

4.

COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.

Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G.

FASEB J. 2001 Dec;15(14):2742-4. Epub 2001 Oct 15.

PMID:
11606477
5.

Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo.

Li W, Jiang HR, Xu XL, Wang J, Zhang J, Liu ML, Zhai LY.

Int J Mol Sci. 2010 Oct 19;11(10):3999-4013. doi: 10.3390/ijms11103999.

6.

Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.

Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D.

Mol Carcinog. 2009 Jan;48(1):56-65. doi: 10.1002/mc.20455.

PMID:
18506760
7.

[Effects of a selective cyclooxygenase 2 inhibitor celecoxib on the proliferation and apoptosis of human prostate cancer cell line PC-3].

Xu S, Zhou WQ, Zhang ZY, Ge JP, Gao JP.

Zhonghua Nan Ke Xue. 2008 Jun;14(6):489-93. Chinese.

PMID:
18649743
8.
9.

Different cell cycle modulation by celecoxib at different concentrations.

Kim YM, Pyo H.

Cancer Biother Radiopharm. 2013 Mar;28(2):138-45. doi: 10.1089/cbr.2012.1264. Epub 2012 Dec 26.

10.

[Celecoxib promotes apoptosis of breast cancer cell line MDA-MB-231 through down-regulation of the NF-kappaB pathway].

Wang L, Liu LH, Shan BE, Zhang C, Sang MX, Li J.

Ai Zheng. 2009 Jun;28(6):569-74. Chinese.

PMID:
19635192
11.

Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors.

Ding X, Zhu C, Qiang H, Zhou X, Zhou G.

Biomed Pharmacother. 2011 Oct;65(7):486-90. doi: 10.1016/j.biopha.2011.06.009. Epub 2011 Aug 27.

PMID:
21993002
12.

Antiproliferative effects of rapamycin and celecoxib in angiosarcoma cell lines.

Bundscherer A, Vogt T, Köhl G, Landthaler M, Hafner C.

Anticancer Res. 2010 Oct;30(10):4017-23.

PMID:
21036716
13.

Antiproliferative effects of selective cyclooxygenase-2 inhibitor modulated by nimotuzumab in estrogen-dependent breast cancer cells.

Wang YX, Gao JX, Wang XY, Zhang L, Liu CM.

Tumour Biol. 2012 Aug;33(4):957-66. doi: 10.1007/s13277-012-0324-4. Epub 2012 Jan 18.

PMID:
22252523
14.

AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells.

Venkatesan P, Bhutia SK, Singh AK, Das SK, Dash R, Chaudhury K, Sarkar D, Fisher PB, Mandal M.

Life Sci. 2012 Oct 22;91(15-16):789-99. doi: 10.1016/j.lfs.2012.08.024. Epub 2012 Aug 24.

PMID:
22922496
15.

[Celecoxib induces cell cycle arrest and apoptosis in human tongue squamous carcinoma cell line Tca8113].

Li WZ, Wang XY, Ding YQ.

Nan Fang Yi Ke Da Xue Xue Bao. 2010 Mar;30(3):486-9. Chinese.

16.

[Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on the proliferation of hepatocellular carcinoma cells].

Tang BD, Zhou Q, Lin QH, Liu SC.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Oct;27(10):1511-3. Chinese.

17.

Anticancer effect of celecoxib via COX-2 dependent and independent mechanisms in human gastric cancers cells.

Liu H, Huang P, Xu X, Liu J, Guo C.

Dig Dis Sci. 2009 Jul;54(7):1418-24. doi: 10.1007/s10620-008-0510-9. Epub 2008 Oct 16.

PMID:
18923901
18.

Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.

Katkoori VR, Manne K, Vital-Reyes VS, Rodríguez-Burford C, Shanmugam C, Sthanam M, Manne U, Chatla C, Abdulkadir SA, Grizzle WE.

Biotech Histochem. 2013 Jan;88(1):38-46. doi: 10.3109/10520295.2012.724713. Epub 2012 Nov 21.

PMID:
23167625
19.
20.

Effect of celecoxib on Ca(2+) handling and viability in human prostate cancer cells (PC3).

Wang JL, Lin KL, Chou CT, Kuo CC, Cheng JS, Hsu SS, Chang HT, Tsai JY, Liao WC, Lu YC, Chen IS, Liu SI, Jan CR.

Drug Chem Toxicol. 2012 Oct;35(4):456-62. doi: 10.3109/01480545.2011.638927. Epub 2011 Dec 14.

PMID:
22168270

Supplemental Content

Support Center